Alzamend Neuro stock analysis
Alzamend Neuro (9ZT) Stock Price & Analysis
9ZT Stock Chart & Stats
- Day’s Range
- EUR 194.40 - EUR 194.40
- 52-Week Range
- EUR 194.40 - EUR 194.40
- Previous Close
- EUR 194.40
- Volume
- N/A
- Average Volume (3M)
- 0
- Market Cap
- EUR 5.18M
- Enterprise Value
- EUR 1.21T
- Total Cash (Recent Filing)
- EUR 7.59M
- Total Debt (Recent Filing)
- EUR 0
- Price to Earnings (P/E)
- ―
- Beta
- 0.00
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Alzamend Neuro News
9ZT FAQ
What was Alzamend Neuro’s price range in the past 12 months?
What is Alzamend Neuro’s market cap?
When is Alzamend Neuro’s upcoming earnings report date?
How were Alzamend Neuro’s earnings last quarter?
Is Alzamend Neuro overvalued?
Does Alzamend Neuro pay dividends?
What is Alzamend Neuro’s EPS estimate?
How many shares outstanding does Alzamend Neuro have?
What happened to Alzamend Neuro’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Alzamend Neuro?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Alzamend Neuro
Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Stephan Jackman
- Employees
- 6
- Website
- www.alzamend.com
- Address
- 3480 Peachtree Road NE, Atlanta, GA, 30326, US
Alzamend Neuro (9ZT) Earnings & Revenues
9ZT Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 2 | 4 | 8 |
| Technical Analysis | 0 | 1 | 1 |
| Moving Averages | 2 | 3 | 7 |












